Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he ...

Still, while Ozempic and Wegovy have secured status ... “The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s ...

Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Dow Jones Top Company Headlines at 11 AM ET: Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges | Charter, ... Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market ...

will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli ...

Ozempic and Wegovy maker Novo Nordisk ousted ... “The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s share price ...

known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges". The company said the ...